ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2023

Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton's tyrosine kinase inhibitor.

Amit Bar-Or et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.